Sicart Associates LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sicart Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$700.03 - $830.35 $33,601 - $39,856	-48 Reduced 10.28%	419 $301,000
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $2,041 - $2,480	-3 Reduced 0.64%	467 $383,000
Q3 2022 Nov 01, 2022	SELL	$573.97 - $724.32 $32,142 - $40,561	-56 Reduced 10.65%	470 $324,000
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $6,580 - $8,866	-12 Reduced 2.23%	526 $311,000
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $227,335 - $266,800	-382 Reduced 41.52%	538 $376,000
Q4 2021 Jan 31, 2022	SELL	$543.48 - $670.97 $69,565 - $85,884	-128 Reduced 12.21%	920 $591,000
Q3 2021 Oct 22, 2021	SELL	$574.03 - $680.96 $8,610 - $10,214	-15 Reduced 1.41%	1,048 $634,000
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $474,873 - $582,736	1,063 New	1,063 $503,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Sicart Associates LLC with notifications on news.